Fullscript adds KBMO Diagnostics for food sensitivity tests

When Community-Acquired Pneumonia (CAP) patients are critically ill and at risk for therapeutic failure, multiple rounds of diagnostic testing may delay the correct course of action—and cause their condition to worsen. This is why the 2025 Delphi Consensus recommends adding PCR-based syndromic panel testing to improve pathogen detection, accelerate results, and optimize antimicrobial management. Learn how the BIOFIRE® FILMARRAY® Pneumonia 👉 Learn how the BIOFIRE® FILMARRAY® Pneumonia Panels detect up to 34 pathogens in about one hour: http://spkl.io/6043AX7E9

When Community-Acquired Pneumonia (CAP) patients are critically ill, the latest 2025 Delphi Consensus recommends adding PCR-based syndromic panel testing to improve pathogen detection and optimize antimicrobial management. This guidance underscores the value of the BIOFIRE® FILMARRAY® Pneumonia Panel, which accelerates results to prevent therapeutic failure and worsening patient conditions. BioFire Defense is the sole supplier of bioMérieux’s BioFire product line to DHA care sites. We ensure your facility has the diagnostic tools recommended by leading consensus groups

From our Hospital-Onset Bacteremia and Fungemia Playbook ➡️ Monitoring is integral to ensuring the continuity and sustainability of an HOB program. In addition to tracking and trending performance on the HOB measure, organizations will want to monitor metrics that correspond to action areas and opportunities for improvement identified in previous phases. From these metrics, the HOB Team can build a base of evidence to understand whether processes and procedures are being successfully implemented, the extent to which process changes contribute to improved outcomes, and whether improvements are sustained over time and consistent across patient populations. For example, this figure illustrates metrics related to blood cultures, from initial sample collection to treatment 👇 Learn more: https://bit.ly/4gPiZsZ

November is C. difficile Awareness Month—an important time to spotlight a serious healthcare challenge that affects thousands of patients each year. C. difficile is a highly contagious bacterium that causes severe diarrhea and colitis, particularly following antibiotic use. The CDC reports that patients are up to 10× more likely to contract C. difficile while on antibiotics or within three months after treatment. This underscores a critical need: accurate, reliable diagnostic testing to protect patient safety and improve outcomes. The healthcare industry continues to advance molecular QC solutions that help laboratories detect C. difficile with greater precision—ultimately supporting better patient care and infection control protocols. As healthcare marketers and leaders, we have a responsibility to amplify awareness around infection prevention and the diagnostic innovations that make a difference. What steps is your organization taking to address C. difficile and antibiotic stewardship? #CdifficileAwarenessMonth #HealthcareInnovation #PatientSafety #InfectionPrevention #Diagnostics #AntibioticStewardship #HealthcareLeadership

💛 It’s C. difficile Awareness Month. Clostridioides difficile (C. difficile) is a highly contagious bacterium that causes diarrhea and colitis, often following antibiotic use. According to the CDC, people are up to 10x more likely to get C. difficile while on antibiotics or during the three months after, with longer courses potentially doubling their risk. At ZeptoMetrix®, our molecular QC solutions help labs ensure accurate detection of C. difficile and support better patient outcomes. 🔬 Learn more: https://lnkd.in/eDiEagJj #cdifficile #diagnostics #qualitycontrols #antibioticawareness #cdifficileawarenessmonth

📢 Next week kicks off World AMR Awareness Week (WAAW)! Each year, bioMérieux supports this global campaign to help raise awareness of Antimicrobial Resistance (AMR) and promote best practices to reduce the emergence and spread of drug-resistant infections. Visit bioMérieux's Medical Education Hub to access free resources & learn more about AMR and how you can get involved! 👉 https://lnkd.in/dDpmUKSM 

📢 Next week kicks off World AMR Awareness Week (WAAW)! Each year, bioMérieux supports this global campaign to help raise awareness of Antimicrobial Resistance (AMR) and promote best practices to reduce the emergence and spread of drug-resistant infections. Visit bioMérieux's Medical Education Hub to access free resources & learn more about AMR and how you can get involved! 👉 https://lnkd.in/dENJfcXi 

📢 Next week kicks off World AMR Awareness Week (WAAW)! Each year, bioMérieux supports this global campaign to help raise awareness of Antimicrobial Resistance (AMR) and promote best practices to reduce the emergence and spread of drug-resistant infections. Visit bioMérieux's Medical Education Hub to access free resources & learn more about AMR and how you can get involved! 👉 https://lnkd.in/eTEiN3AN 

📢 Next week kicks off World AMR Awareness Week (WAAW)! Each year, bioMérieux supports this global campaign to help raise awareness of Antimicrobial Resistance (AMR) and promote best practices to reduce the emergence and spread of drug-resistant infections. Visit bioMérieux's Medical Education Hub to access free resources & learn more about AMR and how you can get involved! 👉 https://lnkd.in/dvAmm8YD